Effect of asymmetric dimethylarginine (ADMA) on heart failure development

被引：43

作者：

Liu, Xiaoyu ^{[1
]}

Hou, Lei ^{[1
]}

Xu, Dachun ^{[1
]}

Chen, Angela ^{[2
,3
]}

Yang, Liuqing ^{[2
,3
]}

Zhuang, Yan ^{[2
,3
]}

Xu, Yawei ^{[1
]}

Fassett, John T. ^{[4
]}

Chen, Yingjie ^{[2
,3
]}

机构：

[1] Tongji Univ, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China

[2] Univ Minnesota, Cardiovasc Div, Minneapolis, MN 55455 USA

[3] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN 55455 USA

[4] Graz Univ, Dept Pharmacol & Toxicol, A-8020 Graz, Austria

来源：

NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 2016年 / 54卷

基金：

中国国家自然科学基金; 美国国家卫生研究院;

关键词：

Nitric oxide; Asymmetric dimethylarginine; Dimethylarginine dimethylaminohydrolase-1; Heart failure; NITRIC-OXIDE SYNTHASE; CARDIOVASCULAR RISK-FACTOR; CHRONIC PRESSURE-OVERLOAD; CORONARY-ARTERY-DISEASE; ORPHAN NUCLEAR RECEPTOR; FARNESOID-X-RECEPTOR; MYOCARDIAL-INFARCTION; URSODEOXYCHOLIC ACID; S-NITROSYLATION; L-ARGININE;

D O I：

10.1016/j.niox.2016.02.006

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthases that limits nitric oxide bioavailability and can increase production of NOS derived reactive oxidative species. Increased plasma ADMA is a one of the strongest predictors of mortality in patients who have had a myocardial infarction or suffer from chronic left heart failure, and is also an independent risk factor for several other conditions that contribute to heart failure development, including hypertension, coronary artery disease/atherosclerosis, diabetes, and renal dysfunction. The enzyme responsible for ADMA degradation is dimethylarginine dimethylaminohydrolase-1 (DDAH1). DDAH1 plays an important role in maintaining nitric oxide bioavailability and preserving cardiovascular function in the failing heart. Here, we examine mechanisms of abnormal NO production in heart failure, with particular focus on the role of ADMA and DDAH1. (C) 2016 Elsevier Inc. All rights reserved.

引用

页码：73 / 81

页数：9

共 117 条

[1] Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase [J].

Achan, V ;

Broadhead, M ;

Malaki, M ;

Whitley, G ;

Leiper, J ;

MacAllister, R ;

Vallance, P .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (08) :1455-1459

[2] Interactions between inflammatory activation and endothelial dysfunction selectively modulate valve disease progression in patients with bicuspid aortic valve [J].

Ali, Onn Akbar ;

Chapman, Matthew ;

Thanh Ha Nguyen ;

Chirkov, Yuliy Y. ;

Heresztyn, Tamila ;

Mundisugih, Juan ;

Horowitz, John D. .

HEART, 2014, 100 (10) :800-805

[3] The L-Arginine-Asymmetric Dimethylarginine Ratio is an Independent Predictor of Mortality in Dilated Cardiomyopathy [J].

Anderssohn, Maike ;

Rosenberg, Mark ;

Schwedhelm, Edzard ;

Zugck, Christian ;

Lutz, Matthias ;

Lueneburg, Nicole ;

Frey, Norbert ;

Boeger, Rainer H. .

JOURNAL OF CARDIAC FAILURE, 2012, 18 (12) :904-911

[4] Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus [J].

Anderssohn, Maike ;

Schwedhelm, Edzard ;

Lueneburg, Nicole ;

Vasan, Ramachandran S. ;

Boeger, Rainer H. .

DIABETES & VASCULAR DISEASE RESEARCH, 2010, 7 (02) :105-118

[5] Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia [J].

Arrigoni, FI ;

Vallance, P ;

Haworth, SG ;

Leiper, JM .

CIRCULATION, 2003, 107 (08) :1195-1201

[6]

BAEK KJ, 1993, J BIOL CHEM, V268, P21120

[7] Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms [J].

Barouch, LA ;

Harrison, RW ;

Skaf, MW ;

Rosas, GO ;

Cappola, TP ;

Kobeissi, ZA ;

Hobai, IA ;

Lemmon, CA ;

Burnett, AL ;

O'Rourke, B ;

Rodriguez, ER ;

Huang, PL ;

Lima, JAC ;

Berkowitz, DE ;

Hare, JM .

NATURE, 2002, 416 (6878) :337-340

[8] Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community [J].

Boeger, Rainer H. ;

Sullivan, Lisa M. ;

Schwedhelm, Edzard ;

Wang, Thomas J. ;

Maas, Renke ;

Benjamin, Emelia J. ;

Schulze, Friedrich ;

Xanthakis, Vanessa ;

Benndorf, Ralf A. ;

Vasan, Ramachandran S. .

CIRCULATION, 2009, 119 (12) :1592-U65

[9] An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes [J].

Böger, RH ;

Bode-Böger, SM ;

Tsao, PS ;

Lin, PS ;

Chan, JR ;

Cooke, JP .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) :2287-2295

[10] Asymmetric dimethylarginine, and endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor [J].

Böger, RH .

JOURNAL OF NUTRITION, 2004, 134 (10) :2842S-2847S

← 1 2 3 4 5 6 7 8 9 10 →